Gabriel Mbalaviele
YOU?
Author Swipe
View article: Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation
Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation Open
Evidence indicating that inflammation is commonly associated with ectopic osteogenesis in certain autoimmune and infectious conditions challenges the dogma that inflammatory responses always suppress bone formation. In this study, we find …
View article: Staphylococcus aureus inhibits the NLRP3 inflammasome in macrophages during the early phases of intracellular infection, but not the late phases
Staphylococcus aureus inhibits the NLRP3 inflammasome in macrophages during the early phases of intracellular infection, but not the late phases Open
Staphylococcus aureus (S. aureus) is a highly virulent pathogen responsible for chronic infections such as osteomyelitis. Although its interaction with the host immune system has been widely studied, the specific role of inflammasomes in r…
View article: NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype
NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype Open
Background Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are…
View article: Editorial: Inflammasomes in human diseases and metabolism
Editorial: Inflammasomes in human diseases and metabolism Open
Citation: Mbalaviele G and Ryffel B (2024) Editorial: Inflammasomes in human diseases and metabolism. Front. Immunol. 15:1420303. doi: 10.3389/fimmu.2024.1420303
View article: Author response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Author response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
View article: Author Response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Author Response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Author Response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Author Response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chemotherapy activates inflammasomes to cause inflammation-associated bone loss Open
Chemotherapy is a widely used treatment for a variety of solid and hematological malignancies. Despite its success in improving the survival rate of cancer patients, chemotherapy causes significant toxicity to multiple organs, including th…
View article: Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss Open
The role of the stromal compartment in tumor progression is best illustrated in breast cancer bone metastases, where the stromal compartment supports tumor growth, albeit through poorly defined mechanisms. p38MAPKα is frequently expressed …
View article: Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss Open
Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
View article: Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss Open
Supplementary Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
View article: Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
Data from Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss Open
The role of the stromal compartment in tumor progression is best illustrated in breast cancer bone metastases, where the stromal compartment supports tumor growth, albeit through poorly defined mechanisms. p38MAPKα is frequently expressed …
View article: Tmem178 negatively regulates IL-1β production through inhibition of the NLRP3 inflammasome
Tmem178 negatively regulates IL-1β production through inhibition of the NLRP3 inflammasome Open
Objective Inflammasomes modulate the release of bioactive IL-1β. Excessive IL-1β levels are detected in patients with systemic juvenile idiopathic arthritis (sJIA) and cytokine storm syndrome (CSS) with mutated and unmutated inflammasome c…
View article: NLRP1 inflammasome modulates senescence and senescence-associated secretory phenotype
NLRP1 inflammasome modulates senescence and senescence-associated secretory phenotype Open
Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as the senescence-associated secretory phenotype (SASP). Here, we present evidenc…
View article: NEK7 activates the NLRP1 Inflammasome
NEK7 activates the NLRP1 Inflammasome Open
Inflammasomes including those assembled by NLRP1 and NLRP3 regulate the innate immune system by inducing interleukin (IL)-1β and IL-18 maturation. Inflammasomes are functionally regulated by post-translational modifications such as phospho…
View article: Author response: Glutamine metabolism modulates chondrocyte inflammatory response
Author response: Glutamine metabolism modulates chondrocyte inflammatory response Open
View article: Glutamine metabolism modulates chondrocyte inflammatory response
Glutamine metabolism modulates chondrocyte inflammatory response Open
Osteoarthritis is the most common joint disease in the world with significant societal consequences, but lacks effective disease modifying interventions. The pathophysiology consists of a prominent inflammatory component that can be target…
View article: IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function
IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function Open
Hematopoietic stem/progenitor cells (HSPCs) reside in localized microenvironments, or niches, in the bone marrow that provide key signals regulating their activity. A fundamental property of hematopoiesis is the ability to respond to envir…
View article: Author response: Fracture healing is delayed in the absence of gasdermin-interleukin-1 signaling
Author response: Fracture healing is delayed in the absence of gasdermin-interleukin-1 signaling Open
View article: Fracture healing is delayed in the absence of gasdermin signaling
Fracture healing is delayed in the absence of gasdermin signaling Open
Amino-terminal fragments from proteolytically cleaved gasdermins (GSDMs) form plasma membrane pores that enable the secretion of interleukin-1β (IL-1β) and IL-18. Excessive GSDM- mediated pore formation can compromise the integrity of the …
View article: NLRP3 inflammasome activation triggers gasdermin D–independent inflammation
NLRP3 inflammasome activation triggers gasdermin D–independent inflammation Open
Sustained stimulation of the NLRP3 inflammasome causes inflammation in the absence of GSDMD.
View article: Activation of GSDME compensates for GSDMD deficiency in a mouse model of NLRP3 inflammasomopathy
Activation of GSDME compensates for GSDMD deficiency in a mouse model of NLRP3 inflammasomopathy Open
The D301N NLRP3 mutation in mice (D303N in humans) causes severe multi-organ damage and early death driven by the constitutively activated NLRP3 (NLRP3 ca ) inflammasome. Triggered inflammasomes activate caspase-1 to process IL-1 family cy…
View article: NF-κB-mediated effects on behavior and cartilage pathology in a non-invasive loading model of post-traumatic osteoarthritis
NF-κB-mediated effects on behavior and cartilage pathology in a non-invasive loading model of post-traumatic osteoarthritis Open
These findings underscore the development of behavioral changes in this non-invasive loading model of PTOA and their relationships to NF-κB activation and pathology. They also highlight the potential chondroprotective effects of NF-κB inhi…
View article: Issue Information
Issue Information Open
fitness for a particular purpose, or non-
View article: Inhibition of the NLRP3 inflammasome prevents ovarian aging
Inhibition of the NLRP3 inflammasome prevents ovarian aging Open
Inflammation is a hallmark of many processes during aging and reproductive physiology, negatively affecting female fertility. The goal of this study was to evaluate the role of the NLRP3 inflammasome in ovarian aging and female fertility. …
View article: Author response: Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO
Author response: Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO Open
Article Figures and data Abstract eLife digest Introduction Results Discussion Materials and methods Data availability References Decision letter Author response Article and author information Metrics Abstract Inflammatory osteolysis is go…
View article: Issue Information
Issue Information Open
loss or damage arising out of, or in connection with, the use of or inability to use the